awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q31105792-4737A8B6-181C-470D-9C28-AB68882F1ADA
Q31105792-4737A8B6-181C-470D-9C28-AB68882F1ADA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31105792-4737A8B6-181C-470D-9C28-AB68882F1ADA
Efficacy and safety of empagliflozin in patients with type 2 diabetes from Asian countries: pooled data from four phase III trials.
P2860
Q31105792-4737A8B6-181C-470D-9C28-AB68882F1ADA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31105792-4737A8B6-181C-470D-9C28-AB68882F1ADA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f93025554ccee32198a21a5faceda7bf97841c68
P2860
Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.